FASLODEX is indicated for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
AZ Cancer Support Network
Patient health is at the center of everything we do
At AstraZeneca, our commitment to patient care goes beyond discovering and developing medicines. An important part of that commitment is the support we provide to patients and health care professionals through the AstraZeneca Cancer Support Network (AZ CSN). AZ CSN provides important information about AstraZeneca oncology products. This includes:
- Information on obtaining AstraZeneca medicine
- Help finding answers to questions on prescription drug coverage
For more information, call a Cancer Support Network representative at:
Monday through Friday, 8 AM to 6 PM ET (excluding holidays)